Håkon Reikvam Selected Research

Leukemia

7/2023	Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia.
8/2022	NPM1-Mutated Patient-Derived AML Cells Are More Vulnerable to Rac1 Inhibition.
1/2022	Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.
5/2020	Critical upper airway obstruction as the first symptom of acute myeloid leukemia - an anesthesiologic reminder.
1/2020	Febrile Neutropenia in Acute Leukemia. Epidemiology, Etiology, Pathophysiology and Treatment.
11/2019	Trisomy 8 in acute myeloid leukemia.
1/2018	Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism.
1/2018	The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.
1/2018	Myeloid Sarcoma after Allogenic Stem Cell Transplantation for Acute Myeloid Leukemia: Successful Consolidation Treatment Approaches in Two Patients.
10/2017	Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Håkon Reikvam Research Topics

Disease

39	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2009
19	Neoplasms (Cancer) 10/2023 - 01/2009
15	Leukemia 07/2023 - 02/2012
7	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2011
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 01/2014
6	Infections 01/2023 - 01/2010
6	Inflammation (Inflammations) 01/2023 - 02/2012
5	Sepsis (Septicemia) 01/2023 - 12/2017
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2023 - 01/2021
4	Bronchiolitis Obliterans Syndrome 01/2022 - 08/2014
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 01/2014
4	Thrombosis (Thrombus) 01/2020 - 01/2014
3	Bacteremia 01/2023 - 01/2018
3	Weight Gain 12/2022 - 02/2012
3	Hematologic Diseases (Blood Diseases) 06/2022 - 01/2015
3	Hemorrhage 01/2021 - 04/2009
2	Immunoglobulin Light-chain Amyloidosis 05/2024 - 01/2021
2	Amyloidosis 05/2024 - 01/2021
2	Pure Red-Cell Aplasia 10/2023 - 01/2022
2	Anemia 10/2023 - 06/2009
2	Cytokine Release Syndrome 01/2022 - 11/2021
2	Fever (Fevers) 11/2021 - 10/2018
2	Myeloid Sarcoma (Chloroma) 07/2021 - 01/2018
2	Iron Overload 05/2021 - 01/2021
2	Iron Deficiencies 05/2021 - 06/2009
2	Paraproteinemias (Monoclonal Gammopathy) 04/2021 - 01/2021
2	Philadelphia Chromosome 05/2019 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2018
2	Carcinogenesis 02/2013 - 03/2011
1	Pleural Effusion (Pleural Effusions) 05/2024
1	Avitaminosis (Vitamin Deficiency) 10/2023
1	Hemolysis 10/2023
1	Abscess 10/2023
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 10/2023
1	Breast Neoplasms (Breast Cancer) 04/2023
1	VEXAS syndrome 01/2023
1	Pain (Aches) 01/2023
1	Thrombocytosis (Thrombocythemia) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Frailty 01/2023

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 07/2019 - 01/2010
6	IronIBA 10/2023 - 06/2009
5	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2011
5	ChemokinesIBA 01/2023 - 01/2010
5	Sirolimus (Rapamycin)FDA Link 04/2020 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2014
4	AntibodiesIBA 01/2022 - 02/2010
3	LipidsIBA 01/2023 - 06/2022
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2021 - 04/2012
3	Valproic Acid (Depakote)FDA LinkGeneric 04/2021 - 04/2012
3	Phosphotransferases (Kinase)IBA 01/2018 - 11/2013
3	Metalloproteases (Metalloproteinases)IBA 01/2018 - 03/2010
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2014 - 09/2011
2	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2021
2	rac1 GTP-Binding ProteinIBA 01/2024 - 08/2022
2	Casein Kinase II (Casein Kinase 2)IBA 08/2023 - 07/2023
2	Amino Acids FDA Link 01/2023 - 01/2018
2	Taurine FDA Link 01/2023 - 01/2015
2	Peptides (Polypeptides)IBA 01/2023 - 01/2023
2	SteroidsIBA 01/2023 - 06/2022
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2014
2	Ferritins (Ferritin)IBA 05/2021 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 11/2019
2	Protein Isoforms (Isoforms)IBA 01/2021 - 11/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2017
2	Interleukin-6 (Interleukin 6)IBA 10/2018 - 11/2016
2	Syk KinaseIBA 01/2018 - 01/2018
2	E-SelectinIBA 01/2018 - 01/2014
2	InterleukinsIBA 01/2017 - 03/2011
2	NucleophosminIBA 12/2016 - 03/2015
1	GadoliniumIBA 05/2024
1	Prealbumin (Transthyretin)IBA 05/2024
1	GTP Phosphohydrolases (GTPases)IBA 01/2024
1	Dicloxacillin (Dycill)FDA LinkGeneric 10/2023
1	Vitamin D FDA LinkGeneric 10/2023
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 08/2023
1	Messenger RNA (mRNA)IBA 08/2023
1	Adenosine Triphosphatases (ATPase)IBA 08/2023
1	silmitasertibIBA 07/2023
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	fms-Like Tyrosine Kinase 3IBA 01/2023
1	hypotaurineIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	Synthetic DrugsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	EnzymesIBA 01/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 12/2022
1	Myristic Acid (Tetradecanoic Acid)IBA 12/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2022
1	AcidsIBA 12/2022
1	Triglycerides (Triacylglycerol)IBA 12/2022
1	NSC 23766IBA 08/2022
1	ZINC69391IBA 08/2022

Therapy/Procedure

20	Stem Cell Transplantation 01/2023 - 01/2011
13	Therapeutics 08/2023 - 01/2009
10	Drug Therapy (Chemotherapy) 08/2023 - 01/2010
10	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2017
4	Immunotherapy 01/2022 - 08/2014
2	Aftercare (After-Treatment) 04/2023 - 07/2021
2	Transplantation 01/2023 - 01/2022